Contact Us

PathoLase developed the PinPointe™ FootLaser™, the first clinically proven laser device for the temporary increase of clear nail in patients with onychomycosis, (nail fungus). Learn more about this break-through technology.

Research is focused on the discovery and development of safe, effective and environmentally-sound devices for use in such diverse areas as podiatry, dermatology, dentistry, periodontology, otolaryngology and pulmonology.

Patholase maintains microbiology, bio-optics and engineering Labs with state-of-the-art medical imaging and image analysis as well as clinical studies facilities that include waiting and treatment rooms for subjects. Find out more about our capabilities.

Our team at PathoLase is made up of industry leaders in both business and science who are dedicated to creating innovation in combination with emerging technologies for the treatment and identification of microbial pathogens.

Inspiration for PathoLase and its therapies was borne out of the founder’s desire to help others dealing with what his young daughter, Jessica (August 23, 1991-March 26, 2008), had dealt with, suffering from end-stage respiratory failure that required a double live lobar (lung) transplant. PathoLase’s founder, John Strisower, discovered that respiratory viral, bacterial, fungal and mold related diseases could be treated with germicidal light by innovative delivery systems and procedures.

This spawned a new generation of research into the most efficient germicidal agent—light.

PathoLase is committed to leaving a positive imprint on society and giving back to our community. Find out more.